Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
Open Access
- 1 December 2015
- journal article
- letter
- Published by Springer Nature in Critical Care
- Vol. 19 (1) , 426
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Persistently elevated osteopontin serum levels predict mortality in critically ill patientsCritical Care, 2015
- ‘Biomarking’ infection during continuous renal replacement therapy: still relevant?Critical Care, 2015
- OPN –RevisitedJournal of Clinical and Diagnostic Research, 2015
- Newly Designed CRRT Membranes for Sepsis and SIRS—A Pragmatic Approach for Bedside Intensivists Summarizing the More Recent AdvancesASAIO Journal, 2013
- Osteopontin predicts survival in critically ill patients with acute kidney injuryNephrology Dialysis Transplantation, 2010
- PLASMA CONCENTRATIONS AND CLEARANCE OF PROCALCITONIN DURING CONTINUOUS VENO-VENOUS HEMOFILTRATION IN SEPTIC PATIENTSShock, 2001